companydata.dkcompanydata.dk

Pharmanovia A/S: Financial statements 2018

CVR: 32287824

Source: annual report 2018, Danish Business Authority

01/04/2017 – 31/03/2018

Pharmanovia A/S (CVR 32287824) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 2,645,762 and a net result of DKK -9,237,568. Equity in the 2018 report amounted to DKK -14,039,366. The company had 8 employees in the financial year.

Gross Profit
DKK 2,645,762
Profit/Loss
DKK -9,237,568
Equity
DKK -14,039,366
Total Assets
DKK 23,903,228
Employees
8

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-2.6 mio.-9.2 mio.-14 mio.8
2015-1.5 mio.-2.2 mio.-12.3 mio.4
2014--609 t.-3.4 mio.-10.2 mio.4
2013--1.2 mio.-6.7 mio.-6.8 mio.-
2012--157 t.-586 t.-60 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

Registered as owner of Pharmanovia A/SFeb 28, 2018

As of February 28, 2018, is registered as an owner of Pharmanovia A/S with an ownership share of 100%.

About Pharmanovia A/S

Pharmanovia A/S is a Danish company of the type Aktieselskab based in København S, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Atnahs Pharma Nordics A/S and PHARMANOVIA A/S. The management consists of Christoph Michael Habereder. The board consists of Mohammad Muqtadir Samy (chair), Christoph Michael Habereder and Twan Johannes Anna Nouwen. The company is owned by Atnahs Pharma UK Limited. The company has 3 employees (2026). In 2026, the company reported a gross profit of EUR 11,734,813 and a net result of EUR 7,730,657 compared with DKK 3,839,334 the year before. Equity in the 2026 report amounted to EUR 15,820,601.

Source: annual report 2026, Danish Business Authority